CATEGORIES: Research
voice activated technology

HNF Partners with True Reply, the Future of Data Collection: Voice Activated Technology (VAT)

by | Dec 8, 2018 | 0 comments

True Reply Logo

  • Accessible and innovative new platform allows for HNF to capture the patient’s experience with CMT in their own words
  • Respondents call into a toll free number where they are asked a series of questions
  • Data is then processed with Artificial Intelligence powered analytics to reveal telling insights
  • Pilot study was launched in 2017 at HNF’s Patient-Centered CMT/HNPP Pain Summit (funded by PCORI’s Eugene Washington Engagement Award #EAIN-7238) where patients were asked to use one word to describe their disease. PAIN was the #1 response
  • Internal Review Board (IRB) approved study through HNF’s patient registry, GRIN, captured 292 patient testimonies in their own voice and 27 of these testimonies were presented to the FDA during the Externally-led PFDD Meeting

true reply graphic

So go ahead and speak up.

YOUR VOICE HAS NEVER BEEN MORE POWERFUL THAN NOW!

Learn more on this topic

Related Blog Posts

A New Mouse Model for Charcot-Marie-Tooth (CMT2)

We were recently informed that The Jackson Laboratory (JAX, a nonprofit biomedical research institution headquartered in Bar Harbor, Maine) had taken delivery and will be distributing a newly generated CMT-related mouse model. The new model expresses mutant mitofusin 2, a mitochondrial membrane protein involved in mitochondrial fusion and regulation of vascular smooth muscle cell proliferation.

Hot Off the Press – Potential Treatment for CMT1A

Two recent publications from Pharnext describe a novel synergistic combination of 3 drugs (baclofen, naltrexone and sorbitol) and its effect on CMT1A both in the lab and in a phase II clinical trial. These 3 drugs already approved but for unrelated conditions, are combined at new optimal lower doses and under a new formulation. This novel potential therapeutic is called PXT-3003.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news